Evidence map›Paper›PMID 37987646›Full record

ArticleMicrobial genomics2023

Comparison of carbapenem-susceptible and carbapenem-resistant

Joseph D Lutgring, Alyssa G Kent, Jolene R Bowers, Daniel E Jasso-Selles, Valerie Albrecht, Valerie A Stevens, Ashlyn Pfeiffer, Riley Barnes, David M Engelthaler, J Kristie Johnson and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Imipenem resistance inNew microbes and new infections · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Joseph D LutgringDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alyssa G KentDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jolene R BowersPathogen and Microbiome Division, Translational Genomics Research Institute North, Flagstaff, Arizona, USA.
Daniel E Jasso-SellesPathogen and Microbiome Division, Translational Genomics Research Institute North, Flagstaff, Arizona, USA.
Valerie AlbrechtDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Valerie A StevensDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ashlyn PfeifferPathogen and Microbiome Division, Translational Genomics Research Institute North, Flagstaff, Arizona, USA.
Riley BarnesPathogen and Microbiome Division, Translational Genomics Research Institute North, Flagstaff, Arizona, USA.
David M EngelthalerPathogen and Microbiome Division, Translational Genomics Research Institute North, Flagstaff, Arizona, USA.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Amy S GargisDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Kamile RasheedDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brandi M LimbagoDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Christopher A ElkinsDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Maria KarlssonDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alison L HalpinDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USTranslational Genomics Research Institute · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Anti-Bacterial AgentsGammaproteobacteriaCarbapenemsChromosome MappingDrug Resistance, BacterialUnited StatesAnti-Bacterial AgentsCarbapenemscarbapenem-resistantcarbapenem-resistant Enterobacteralescarbapenem-susceptibleCREgenomic sequencingmolecular epidemiology

Identifiers

PMID37987646
PMCPMC10711308
OpenAlexW4388861310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.